Adherence to deferoxamine therapy: Heeding hippocrates and osler by Watkins, F, Fidler, C, Boultwood, J, Wainscoat, J

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia. by Watkins, F, Fidler, C, Boultwood, J, Wainscoat, J

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q). by Fidler, C, Watkins, F, Bowen, D, Littlewood, T, Wainscoat, J, Boultwood, J

Narrowing and genomic annotation of the critical region of the 5q-syndrome. by Boultwood, J, Fidler, C, Strickson, A, Watkins, F, Jaju, R, Kasprzyk, A, Cheng, J, Wainscoat, J

Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs. by Boultwood, J, Fidler, C, Strickson, A, Watkins, F, Kostrzewa, M, Jaju, R, Müller, U, Wainscoat, J

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase. by Boultwood, J, Peniket, A, Watkins, F, Shepherd, P, McGale, P, Richards, S, Fidler, C, Littlewood, T, Wainscoat, J

Analysis of telomere length in chronic myelogenous leukemia. by Boultwood, J, Fidler, C, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Shepherd, P, Gaiger, A, Littlewood, T, Wainscoat, J

Analysis or telomere length in chronic myelogenous leukemia by Fidler, C, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Shepherd, P, Gaiger, A, Littlewood, T, Boultwood, J, Wainscoat, J

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia. by Boultwood, J, Pellagatti, A, Watkins, F, Campbell, L, Esoof, N, Cross, N, Eagleton, H, Littlewood, T, Fidler, C, Wainscoat, J

Telomere length shortening in CML is associated with reduced time to accelerated phase but does not influence overall survival. by Boultwood, J, Watkins, F, Shepherd, P, McGale, P, Richards, S, Fidler, C, Littlewood, T, Peniket, A, Wainscoat, J, Hatton, C

A novel gene is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood AML. by Jaju, R, Fidler, C, Haas, O, Strickson, A, Watkins, F, Clark, K, Aplan, P, Kearney, L, Boultwood, J, Wainscoat, J

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. by Boultwood, J, Fidler, C, Strickson, A, Watkins, F, Gama, S, Kearney, L, Tosi, S, Kasprzyk, A, Cheng, J, Jaju, R, Wainscoat, J

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. by Boultwood, J, Fidler, C, Shepherd, P, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Gaiger, A, Littlewood, T, Peniket, A, Wainscoat, J

Isolation and analysis of novel candidate genes mapping to the critical region of the 5q-syndrome. by Boultwood, J, Fidler, C, Strickson, A, Watkins, F, Kostrzewa, M, Jaju, R, Muller, U, Jabs, E, Cheng, J, Wainscoat, J

A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. by Jaju, R, Fidler, C, Haas, O, Strickson, A, Watkins, F, Clark, K, Cross, N, Cheng, J, Aplan, P, Kearney, L, Boultwood, J, Wainscoat, J

Isolation and analysis of novel genes mapping to the critical region of the 5q-syndrome by Fidler, C, Strickson, A, Soularue, P, Kostrzewa, M, Jaju, R, Watkins, F, Monaco, A, Muller, U, Lovett, M, Jabs, E, Auffray, C, Boultwood, J, Wainscoat, J

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes. by Pellagatti, A, Esoof, N, Watkins, F, Langford, C, Vetrie, D, Campbell, L, Fidler, C, Cavenagh, J, Eagleton, H, Pushkaran, B, Kwan, M, Wainscoat, J, Boultwood, J

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. by Pellagatti, A, Esoof, N, Watkins, F, Langford, C, Vetrie, D, Campbell, L, Fidler, C, Cavenagh, J, Eagleton, H, Gordon, P, Woodcock, B, Pushkaran, B, Kwan, M, Wainscoat, J, Boultwood, J